Evidence map›Paper›PMID 37887220›Full record

ReviewAntibiotics (Basel, Switzerland)2023

Ana-Katharina E Gehrke, Constanza Giai, Marisa I Gómez

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. An outbreak of Panton-Valentine leucocidin-producing meticillin-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  3. Article
  4. Article
  5. Fibroblasts resistScience advances · 2026
    Article
  6. Review
  7. Pharmaceutics · 2026
    Article
  8. Article
  9. Baloxavir Exhibits Antibacterial Activity AgainstInternational journal of molecular sciences · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Phenotypic and Genotypic Characterization ofPathogens (Basel, Switzerland) · 2025
    Article
  18. Article
  19. Article
  20. Antimicrobial resistance ofVeterinary world · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Ana-Katharina E GehrkeCentro de Estudios Biomédicos, Básicos, Aplicados y Desarrollo (CEBBAD), Departamento de Investigaciones Biomédicas y Biotecnológicas, Universidad Maimónides, Buenos Aires C1405BCK, Argentina.
Constanza GiaiInstituto de Histología y Embriología de Mendoza, Universidad Nacional de Cuyo-(UNCuyo) CONICET, Mendoza M5502JMA, Argentina.
Marisa I GómezCentro de Estudios Biomédicos, Básicos, Aplicados y Desarrollo (CEBBAD), Departamento de Investigaciones Biomédicas y Biotecnológicas, Universidad Maimónides, Buenos Aires C1405BCK, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad Maimónides · ARUniversity of Buenos Aires · AR

Funding

Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT 2018-3613Fundación Científica Felipe Fiorellino Intramural funding
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adaptationpersistenceStaphylococcus aureus

Identifiers

PMID37887220
PMCPMC10604630
OpenAlexW4387422396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.